Author Correction: Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager

Affiliations

• ¹ Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
• ² Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
• ³ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁴ Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
• ⁵ Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
• ⁶ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
• ⁷ Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
• ⁸ Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
• ⁹ Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
• ¹⁰ Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
• ¹¹ Institute for RNA Innovation, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.
• ¹² Center for Precision Engineering for Health, University of Pennsylvania, Philadelphia, PA, USA. mjmitch@seas.upenn.edu.